Committed to sharing our science

Committed to sharing our science

393 results available

Improvement in KCCQ Scores in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in the REDWOOD HCM OLE Study

Poster, HFSA 2022 Annual Scientific Meeting
Saberi S, et al
Washington, DC
October 2, 2022
Efficacy and Safety of Aficamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results from the Randomized Evaluation of Dosing with CK-3773274 in Hypertrophic Cardiomyopathy (REDWOOD-HCM) Open-Label Extension Study

Presentation (Encore), HFSA 2022 Annual Scientific Meeting
Masri A, et al
Washington, DC
October 1, 2022
Prevalence and Excess Risk of Hospitalization in Heart Failure with Reduced Ejection Fraction

Poster, HFSA 2022 Annual Scientific Meeting
Desai, NR, et al
Washington, DC
October 1, 2022
Safety, Efficacy, and Quantitative Understanding of Obstruction, Impact of Aficamten in Hypertrophic Cardiomyopathy (SEQUOIA-HCM) Study Design: A Phase 3 Study

Poster, HFSA 2022 Annual Scientific Meeting
Coats C, et al
Washington, DC
October 1, 2022
Withdrawal of Background Standard of Care Medical Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in REDWOOD HCM OLE

Presentation, 2022 HCM Society Scientific Sessions
Masri A, et al
National Harbor, MD
September 30, 2022